Study of Brain Imaging With Nuclear Technology in Individuals With Parkinsonian Syndrome

NCT00132626 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Parkinson's Disease
Parkinsonian Syndrome

Interventions

DRUG: [123I]ß-CIT and SPECT imaging

Sponsor

Institute for Neurodegenerative Disorders

Collaborators

[object Object]
[object Object]